Cassidy Noah A J, Fish Carolyn S, Levy Claire N, Roychoudhury Pavitra, Reeves Daniel B, Hughes Sean M, Schiffer Joshua T, Benki-Nugent Sarah, John-Stewart Grace, Wamalwa Dalton, Jerome Keith R, Overbaugh Julie, Hladik Florian, Lehman Dara A
Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
iScience. 2021 Dec 11;25(1):103615. doi: 10.1016/j.isci.2021.103615. eCollection 2022 Jan 21.
A major barrier to conducting HIV cure research in populations with the highest HIV burden is the lack of an accurate assay to quantify the replication-competent reservoir across the dominant global HIV-1 subtypes. Here, we modify a subtype B HIV-1 assay that quantifies both intact and defective proviral DNA, adapting it to accommodate cross-subtype HIV-1 sequence diversity. We show that the cross-subtype assay works on subtypes A, B, C, D, and CRF01_AE and can detect a single copy of intact provirus. In longitudinal blood samples from Kenyan infants infected with subtypes A and D, patterns of intact and total HIV DNA follow the decay of plasma viral load over time during antiretroviral therapy, with intact HIV DNA comprising 7% (range 1%-33%) of the total HIV DNA during HIV RNA suppression. This high-throughput cross-subtype reservoir assay will be useful in HIV cure research in Africa and Asia, where HIV prevalence is highest.
在艾滋病毒负担最重的人群中开展艾滋病毒治愈研究的一个主要障碍是缺乏一种准确的检测方法来量化全球主要艾滋病毒-1亚型中具有复制能力的病毒库。在此,我们改进了一种B亚型艾滋病毒-1检测方法,该方法可对完整和缺陷型前病毒DNA进行定量,并对其进行调整以适应跨亚型艾滋病毒-1序列多样性。我们表明,这种跨亚型检测方法适用于A、B、C、D和CRF01_AE亚型,并且能够检测到单拷贝的完整前病毒。在感染了A和D亚型的肯尼亚婴儿的纵向血样中,在抗逆转录病毒治疗期间,完整和总艾滋病毒DNA的模式随血浆病毒载量随时间的衰减而变化,在艾滋病毒RNA被抑制期间,完整艾滋病毒DNA占总艾滋病毒DNA的7%(范围为1%-33%)。这种高通量跨亚型病毒库检测方法将在艾滋病毒患病率最高的非洲和亚洲的艾滋病毒治愈研究中发挥作用。